-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Haoyuan Pharmaceutical (688131.SH) announced that due to arrangements such as fund expiration and shareholders' own financial needs, Suxin Fund plans to reduce its holdings by no more than 546,400 shares of the company through centralized bidding. The proposed reduction ratio will not exceed 0.26% of the company's total share capital. The current holdings reduction plan will be carried out within 3 months after 3 trading days from the date of disclosure of the announcement.

Zhitongcaijing·12/21/2025 08:01:01
Listen to the news
Zhitong Finance App News, Haoyuan Pharmaceutical (688131.SH) announced that due to arrangements such as fund expiration and shareholders' own financial needs, Suxin Fund plans to reduce its holdings by no more than 546,400 shares of the company through centralized bidding. The proposed reduction ratio will not exceed 0.26% of the company's total share capital. The current holdings reduction plan will be carried out within 3 months after 3 trading days from the date of disclosure of the announcement.